Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 12/2023

07.07.2023 | Original Article

Short- and Midterm outcomes of modified robotic tricuspid annuloplasty for secondary tricuspid regurgitation

verfasst von: Kazuki Noda, Satsuki Fukushima, Takashi Kakuta, Satoshi Kainuma, Naonori Kawamoto, Naoki Tadokoro, Ayumi Ikuta, Tomoyuki Fujita

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite the growing popularity of robotically assisted mitral repair, robotically assisted tricuspid repair has not been widely adopted. We assessed the safety and feasibility of robotic tricuspid annuloplasty with continuous sutures for tricuspid regurgitation (TR).

Methods and results

We studied consecutive 68 patients (median age, 74 years) with secondary TR who underwent tricuspid annuloplasty using continuous sutures with (n = 61) and without mitral valve repair (n = 7) from 2018 to 2021. Robotic tricuspid annuloplasty consists of continuous sutures with flexible prosthetic band to the tricuspid annulus using two V-Loc barbed sutures (Medtronic Inc., Minneapolis, MN). Concomitant maze procedure was performed in 45 (66%) patients. Robotic tricuspid annuloplasty with continuous sutures was successfully performed. There was no in-hospital or 30-day mortality; 65 patients (96%) did not experience major surgery-related complications. Preoperatively, the TR grade was mild in 20 (29%) patients and mildly higher in 48 (71%). Postoperatively, the TR severity significantly improved, with TR grade mildly higher in 9% at hospital discharge and 7% at 1-year follow-up (p < 0.001). The 1-year and 2-year freedom rates from heart failure were 98% and 95%, respectively.

Conclusions

Robotic tricuspid annuloplasty with continuous sutures is safe and feasible alone or concomitant with mitral valve repair. It offered sustained improvement in TR severity and might prevent heart failure readmission.
Literatur
1.
Zurück zum Zitat Izumi C, Miyake M, Takahashi S, Matsutani H, Hashiwada S, Kuwano K, et al. Progression of isolated tricuspid regurgitation late after left-sided valve surgery: clinical features and mechanisms. Circ J. 2011;75:2902–7.CrossRefPubMed Izumi C, Miyake M, Takahashi S, Matsutani H, Hashiwada S, Kuwano K, et al. Progression of isolated tricuspid regurgitation late after left-sided valve surgery: clinical features and mechanisms. Circ J. 2011;75:2902–7.CrossRefPubMed
2.
Zurück zum Zitat Lee H, Sung K, Kim WS, Lee YT, Park SJ, Carriere KC, et al. Clinical and hemodynamic influences of prophylactic tricuspid annuloplasty in mechanical mitral valve replacement. J Thorac Cardiovasc Surg. 2016;151:788–95.CrossRefPubMed Lee H, Sung K, Kim WS, Lee YT, Park SJ, Carriere KC, et al. Clinical and hemodynamic influences of prophylactic tricuspid annuloplasty in mechanical mitral valve replacement. J Thorac Cardiovasc Surg. 2016;151:788–95.CrossRefPubMed
3.
Zurück zum Zitat Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72–227.PubMed Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72–227.PubMed
4.
Zurück zum Zitat Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2021;60:727–800.CrossRefPubMed Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2021;60:727–800.CrossRefPubMed
5.
Zurück zum Zitat Lewis CT, Stephens RL, Tyndal CM, Cline JL. Concomitant robotic mitral and tricuspid valve repair: technique and early experience. Ann Thorac Surg. 2014;97:782–7.CrossRefPubMed Lewis CT, Stephens RL, Tyndal CM, Cline JL. Concomitant robotic mitral and tricuspid valve repair: technique and early experience. Ann Thorac Surg. 2014;97:782–7.CrossRefPubMed
6.
Zurück zum Zitat Kawamoto N, Fukushima S, Shimahara Y, Yamasaki T, Matsumoto Y, Yamashita K, et al. Benefit and risk of minimally invasive mitral valve repair for type II dysfunction—propensity score matched comparison. Circ J. 2018;83:224–31.CrossRefPubMed Kawamoto N, Fukushima S, Shimahara Y, Yamasaki T, Matsumoto Y, Yamashita K, et al. Benefit and risk of minimally invasive mitral valve repair for type II dysfunction—propensity score matched comparison. Circ J. 2018;83:224–31.CrossRefPubMed
7.
Zurück zum Zitat Toya T, Fujita T, Fukushima S, Shimahara Y, Kume Y, Yamashita K, et al. Efficacy of regional saturation of oxygen monitor using near-infrared spectroscopy for lower limb ischemia during minimally invasive cardiac surgery. J Artif Organs. 2018;21:420–6.CrossRefPubMed Toya T, Fujita T, Fukushima S, Shimahara Y, Kume Y, Yamashita K, et al. Efficacy of regional saturation of oxygen monitor using near-infrared spectroscopy for lower limb ischemia during minimally invasive cardiac surgery. J Artif Organs. 2018;21:420–6.CrossRefPubMed
8.
Zurück zum Zitat Kakuta T, Fukushima S, Shimahara Y, Yajima S, Tadokoro N, Minami K, et al. Early results of robotically assisted mitral valve repair in a single institution: report of the first 100 cases. Gen Thorac Cardiovasc Surg. 2020;68:1079–85.CrossRefPubMed Kakuta T, Fukushima S, Shimahara Y, Yajima S, Tadokoro N, Minami K, et al. Early results of robotically assisted mitral valve repair in a single institution: report of the first 100 cases. Gen Thorac Cardiovasc Surg. 2020;68:1079–85.CrossRefPubMed
9.
Zurück zum Zitat Watanabe G, Ishikawa N. Use of barbed suture in robot-assisted mitral valvuloplasty. Ann Thorac Surg. 2015;99:343–5.CrossRefPubMed Watanabe G, Ishikawa N. Use of barbed suture in robot-assisted mitral valvuloplasty. Ann Thorac Surg. 2015;99:343–5.CrossRefPubMed
10.
Zurück zum Zitat Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation of dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005;79:127–32.CrossRefPubMed Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation of dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005;79:127–32.CrossRefPubMed
11.
Zurück zum Zitat Carpentier A, Deloche A, Hanania G, Forman J, Sellier P, Piwnica A, et al. Surgical management of acquired tricuspid valve disease. J Thorac Cardiovasc Surg. 1974;67:53–65.CrossRefPubMed Carpentier A, Deloche A, Hanania G, Forman J, Sellier P, Piwnica A, et al. Surgical management of acquired tricuspid valve disease. J Thorac Cardiovasc Surg. 1974;67:53–65.CrossRefPubMed
12.
Zurück zum Zitat Sakon Y, Murakami T, Fujii H, Takahashi Y, Morisaki A, Yamane K, et al. New insight into tricuspid valve anatomy from 100 hearts to reappraise annuloplasty methodology. Gen Thorac Cardiovasc Surg. 2019;67:758–64.CrossRefPubMed Sakon Y, Murakami T, Fujii H, Takahashi Y, Morisaki A, Yamane K, et al. New insight into tricuspid valve anatomy from 100 hearts to reappraise annuloplasty methodology. Gen Thorac Cardiovasc Surg. 2019;67:758–64.CrossRefPubMed
13.
Zurück zum Zitat Hata H, Fujita T, Miura S, Shimahara Y, Kume Y, Matsumoto Y, et al. Long- term outcomes of suture vs ring tricuspid annuloplasty for functional tricuspid regurgitation. Circ J. 2017;81:1432–8.CrossRefPubMed Hata H, Fujita T, Miura S, Shimahara Y, Kume Y, Matsumoto Y, et al. Long- term outcomes of suture vs ring tricuspid annuloplasty for functional tricuspid regurgitation. Circ J. 2017;81:1432–8.CrossRefPubMed
Metadaten
Titel
Short- and Midterm outcomes of modified robotic tricuspid annuloplasty for secondary tricuspid regurgitation
verfasst von
Kazuki Noda
Satsuki Fukushima
Takashi Kakuta
Satoshi Kainuma
Naonori Kawamoto
Naoki Tadokoro
Ayumi Ikuta
Tomoyuki Fujita
Publikationsdatum
07.07.2023
Verlag
Springer Nature Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 12/2023
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-023-01950-7

Weitere Artikel der Ausgabe 12/2023

General Thoracic and Cardiovascular Surgery 12/2023 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.